Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abiraterone”

317 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 317 results

Not applicableStudy completedNCT02364531
What this trial is testing

A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting

Who this might be right for
Prostatic Neoplasms
Janssen Inc. 194
Testing effectiveness (Phase 2)Ended earlyNCT03764540
What this trial is testing

Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide

Who this might be right for
Metastatic Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 57
Early research (Phase 1)Ended earlyNCT01741753
What this trial is testing

BKM120+Abiraterone Acetate for Metastatic CRPC

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 4
Large-scale testing (Phase 3)Active Not RecruitingNCT04493853
What this trial is testing

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Who this might be right for
Hormone-Sensitive Prostate Cancer
AstraZeneca 1,012
Post-approval studies (Phase 4)Looking for participantsNCT07001709
What this trial is testing

Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)

Who this might be right for
Prostate CancerPain Cancer
Deventer Ziekenhuis 29
Large-scale testing (Phase 3)Active Not RecruitingNCT04497844
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 696
Testing effectiveness (Phase 2)Study completedNCT02125357
What this trial is testing

Sequencing Abiraterone and Enzalutamide in mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
British Columbia Cancer Agency 202
Testing effectiveness (Phase 2)Looking for participantsNCT06689163
What this trial is testing

The Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 66
Testing effectiveness (Phase 2)Ended earlyNCT01717898
What this trial is testing

Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castrate-resistant Prostate Cancer
Charles Ryan 6
Large-scale testing (Phase 3)Active Not RecruitingNCT03348670
What this trial is testing

Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms

Who this might be right for
Prostate Cancer
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair 600
Testing effectiveness (Phase 2)Study completedNCT02160353
What this trial is testing

Neo-adjuvant Abiraterone Prostate Study

Who this might be right for
High Risk Localised Prostate Carcinoma
Cancer Trials Ireland 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT06212583
What this trial is testing

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 88
Testing effectiveness (Phase 2)WithdrawnNCT02159690
What this trial is testing

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

Who this might be right for
Prostate CancerLocalized Prostate Cancer
Kenneth Pienta, MD
Early research (Phase 1)Study completedNCT04863105
What this trial is testing

Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers

Who this might be right for
Healthy Volunteers
The Affiliated Hospital of Qingdao University 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT02807805
What this trial is testing

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 37
Large-scale testing (Phase 3)Active Not RecruitingNCT03732820
What this trial is testing

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 895
Not applicableStudy completedNCT02813226
What this trial is testing

Assessment of New Molecular Imaging Strategies for Prostate Cancer

Who this might be right for
Prostate Cancer
Ontario Clinical Oncology Group (OCOG) 36
Not applicableStudy completedNCT01857908
What this trial is testing

A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone

Who this might be right for
Prostate Cancer (Adenocarcinoma)
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Ended earlyNCT04556617
What this trial is testing

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Opna Bio LLC 19
Testing effectiveness (Phase 2)Study completedNCT00755885
What this trial is testing

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK 77
Next Page